A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Enlivex Therapeutics Ltd’s current trading price is -28.41% away from its 52-week high, while its distance from the 52-week low is 55.54%. The stock’s price range for this time frame has been between $0.81 and $1.76. The trading volume of the company’s shares in the Healthcare reached around 1.05 million for the day, which was evidently higher than the average daily volume of 81710.0 over the last three months.
Currently, the stock price of Enlivex Therapeutics Ltd (ENLV) is $1.26. In the most recent trading session, the stock underwent a significant upswing, peaking at $13.0 after opening at $1.26. The stock touched a low of $7.0 before closing at $1.12.
In terms of market performance, Enlivex Therapeutics Ltd had a somewhat regular. The highest value for the stock in the past year was $1.76 on 09/13/24, while the lowest value was $0.81 on 11/21/24.
How Financial Performance Impacts Market Capitalization
Enlivex Therapeutics Ltd (ENLV) has experienced a quarterly rise of 27.98% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 30.05M and boasts a workforce of 36 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.0533, with a change in price of +0.1800. Similarly, Enlivex Therapeutics Ltd recorded 100,719 in trading volume during the last 100 days, posting a change of +16.67%.
How ENLV’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for ENLV stands at 0.02. Similarly, the long-term debt-to-equity ratio is also 0.01.
ENLV Stock Stochastic Average
The raw stochastic average for Enlivex Therapeutics Ltd over the last 50 days is presently at 75.00%. This reflects a surge from the raw stochastic average of the previous 20 days, which was noted at 55.56%. Further, the company’s Stochastic %K and %D values for the last 20 days were 23.95% and 18.93%, respectively.
ENLV Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. This year’s metric has recorded a Price decrease of -11.27%. However, over the past six months, we’ve seen a weaker performance of 6.78%. The price of ENLV fallen by 4.13% over the last 30 days. And in the last five days, it has surged by 5.88%.
